Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03062384 · ClinicalTrials.gov registry record · NA
AT-001 for Long-term Preservation of Brain Health in Aging
A NA study, sponsored by University of Kentucky.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
NCT03062384 is a NA study that has completed, run by University of Kentucky. The registered enrollment target is 95 participants.
The verdict
NCT03062384, a NA study, has completed, sponsored by University of Kentucky.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if the use of a yeast-selenium supplement (AT-001) is safe in elderly subjects who do not have dementia, and further, to see if the supplement improves tests that are related to brain health.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT AT-001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2016-05 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03062384
The ClinicalTrials.gov registry entry for NCT03062384 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kentucky, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03062384 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03062384 about?
NCT03062384 is a clinical study titled "AT-001 for Long-term Preservation of Brain Health in Aging". The purpose of this study is to evaluate if the use of a yeast-selenium supplement (AT-001) is safe in elderly subjects who do not have dementia, and further, to see if the supplement improves tests that are related to brain health.
What is the current status of trial NCT03062384?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2016-05. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT03062384?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), AT-001 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03062384?
This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.